Pure Global AI
NCT06253013Recruiting

CHARM-COPD Program of Care

A Program of Care in Chronic Obstructive Pulmonary Disease Involving Virtual Pulmonary Rehabilitation, Integrated Care and Remote Clinical Monitoring After Discharge From a Recent Exacerbation: Mixed-Methods Study on Feasibility
University Health Network, TorontoClinicalTrials.govdeviceDevice trial
Verified
Study focus
Disease/Condition
Chronic Obstructive Pulmonary Disease
Drug/Device/Intervention
Hyfe Smartwatch
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
University Health Network, Toronto
Location
Toronto, Canada
Timeline & enrollment
Phase
N/A
Start date
Sep 15, 2023
End date
Jun 01, 2025
Enrollment
100 participants
Primary outcome

Feasibility of the program and research study,Acceptability by patients and clinicians,Actual usage over 90 days

Summary

The investigators' goal for this project is to evaluate the feasibility, acceptability, and
 actual usage of a program of care for patients with COPD recently discharged after an acute
 exacerbation. The program of care includes virtual pulmonary rehabilitation, integrated care,
 and remote clinical monitoring.

ICD-10 classifications
Other chronic obstructive pulmonary diseaseChronic obstructive pulmonary disease, unspecifiedOther specified chronic obstructive pulmonary diseaseChronic obstructive pulmonary disease with acute exacerbation, unspecifiedChronic obstructive pulmonary disease with acute lower respiratory infection
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06253013
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06253013 through Pure Global AI's free database. This phase not specified trial is sponsored by University Health Network, Toronto and is currently Recruiting. The study focuses on Chronic Obstructive Pulmonary Disease. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.